Adverse events590

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 590

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	184	926	249
other	Anaemia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	174	912	243
other	Leukopenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	73	926	134
other	Leukopenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	51	912	96
other	Neutropenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	232	926	411
other	Neutropenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	220	912	403
other	Thrombocytopenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	25	926	29
other	Thrombocytopenia	Blood and lymphatic system disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	162	912	297
other	Dry eye	Eye disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	62	926	69
other	Dry eye	Eye disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	75	912	87
other	Lacrimation increased	Eye disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	112	926	120
other	Lacrimation increased	Eye disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	73	912	75
other	Vision blurred	Eye disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	42	926	44
other	Vision blurred	Eye disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	46	912	49
other	Abdominal pain	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	83	926	103
other	Abdominal pain	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	86	912	110
other	Abdominal pain upper	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	83	926	90
other	Abdominal pain upper	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	87	912	110
other	Constipation	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab, Pertuzumab, and Taxane	287	926	369
other	Constipation	Gastrointestinal disorders	Anthracycline Followed by Trastuzumab Emtansine and Pertuzumab	299	912	413

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01966471/events

API reference For AI assistants

Adverse events590

Sources 3

Read this list from software.